Horse Sarcoid Immunotherapy: Welfare Evidence and Emerging Treatments

Immunotherapy approaches for equine sarcoids offer welfare-positive alternatives to surgery with lower recurrence risk in selected cases.

Key Facts

Immunotherapy for equine sarcoids aims to stimulate immune recognition and rejection of tumour tissue.
BCG immunotherapy has been used for periocular sarcoids with variable efficacy and some adverse reaction risk.
Cisplatin intralesional injection shows efficacy in smaller nodular sarcoids in published case series.
Acyclovir cream has shown limited but some evidence for effect in occult and flat sarcoid types.
Topical chemotherapy products including AW4-LUDES and Topcide have documented efficacy in some sarcoid types.
Combination approaches using multiple modalities are increasingly used by specialist equine dermatologists.
Recurrence after immunotherapy is lower than after simple surgical excision for most sarcoid types.

Welfare Considerations

Immunotherapy approaches for sarcoids represent a welfare improvement over simple surgical excision, which has the highest documented recurrence rate of any treatment approach. The challenge of sarcoid management is that the treatment response varies by sarcoid type, location, and size, requiring specialist assessment to match treatment to case. Welfare considerations include treatment frequency, restraint requirements, and adverse reaction risk alongside efficacy. Horses in experienced specialist hands with access to the full range of therapeutic options have the best welfare outcomes. The growth of specialist equine dermatology and oncology services improves access to evidence-based treatment selection for horse owners committed to optimal sarcoid welfare outcomes.

What You Can Do

Consult a specialist equine dermatologist or oncologist for sarcoids in challenging locations.
Avoid simple surgical excision for sarcoids without specialist advice on recurrence risk.
Discuss the full range of immunotherapy and topical options with your specialist before treatment selection.
Monitor treated areas closely for recurrence and respond promptly if regrowth is detected.
Document sarcoid location, type, and treatment history carefully to inform future management decisions.